Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/13/2003EP1333836A2 Cephalosporin antibiotics and prodrugs thereof
08/13/2003EP1333835A1 The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333832A1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333828A2 Prevention of development of dyskinesias
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333826A2 Phase transfer catalyzed glycosidation of an indolocarbazole
08/13/2003EP1333825A1 Method for enhanced delivery of oxybutynin and compositions thereof
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333822A2 Treatment of diseases with adamantane derivatives
08/13/2003EP1333821A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
08/13/2003EP1333820A2 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
08/13/2003EP1333819A2 Inhalative solution formulation containing a tiotropium salt
08/13/2003EP1333818A2 Titratable dosage transdermal delivery system
08/13/2003EP1333816A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
08/13/2003EP1333812A1 Microgranules based on active principle and method for making same
08/13/2003EP1333811A1 Liposomal formulation of mitoxantrone
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333807A2 Extended release erythromycin derivatives
08/13/2003EP1333805A2 Cosmetic method of treating skin
08/13/2003EP1333801A2 Compositions for cleansing skin and treating acne
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1256340B1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1220656B1 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase
08/13/2003EP1216244B1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
08/13/2003EP1165540B1 Tetrahydropyran derivatives and their use as therapeutic agents
08/13/2003EP1158990A4 Administration of an anti-endotoxin drug by intravenous infusion
08/13/2003EP1148793B1 Method of preparing microparticles of phytosterols or phytostanols
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP1143981A4 Treatment and prevention of hiv and other viral infections
08/13/2003EP1143942B1 Use of gaba-b receptor ligands for the manufacture of medicaments for the treatment of neurodegenerative diseases
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP1135036A4 Smoking products containing antioxidants
08/13/2003EP1133296B1 Novel therapeutic application of nicergoline
08/13/2003EP1132090B1 Method for producing an agent for treating ulcers of the organism
08/13/2003EP1115386B1 Medicament for the treatment of infection
08/13/2003EP1112495B1 Disaccharide derivatives
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP1034174B1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
08/13/2003EP1023279B8 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/13/2003EP1000941B1 Diaminorhodamine derivatives
08/13/2003EP0991773B1 Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
08/13/2003EP0987269B1 Salts of optically active sulfoxide derivative
08/13/2003EP0979083B1 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
08/13/2003EP0956287B1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0927179B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0914096B1 Microparticles and their use in wound therapy
08/13/2003EP0910380B1 Substituted benzylidene indenyl formamides, acetamides and propionamides
08/13/2003EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003EP0885888B1 Isoquinoline derivatives and drugs
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003EP0871441B1 Dfmo and taxol for the treatment or prevention of breast cancer
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0837859B1 Tetrahydrofuran antifungals
08/13/2003EP0814809B1 Aryl thioxanthines
08/13/2003EP0808313B1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/13/2003EP0784470B1 Liposome-formulations for treatment of viral diseases
08/13/2003EP0759755B1 Thiadiazolylalkoxyphenyl derivatives, their preparation and their use anti-picornaviral agents
08/13/2003EP0751774B1 Hypocholesterolemic mercaptoacetylamide disulfide derivatives
08/13/2003EP0743842B1 Drug-containing adhesive composite transdermal delivery device
08/13/2003EP0665843B1 Substituted quinuclidines as substance p antagonists
08/13/2003EP0588859B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
08/13/2003CN1436304A Method and apparatus for monitoring anti-platelet agent
08/13/2003CN1436245A Lipopolysaccharides (LPS) extracted from Escherichia coli
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1436233A Methods and compositions based on VEGF antisense oligonucleotides
08/13/2003CN1436193A Antitumoral ecteinascidin derivs
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436191A Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
08/13/2003CN1436189A Non-nucleoside reverse transcriptase inhibitors
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436186A Process for preparation of sulfonamide derivs. and crystals thereof
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436179A Oxadiazole derivs. having anticancer effects
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436170A Vitamin D derivs.
08/13/2003CN1436168A Beta-amino acid nitrile derivs.
08/13/2003CN1436084A Remedies for allergic diseases and process for producing same
08/13/2003CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity
08/13/2003CN1436082A 3'-or 2'-hydroxymethyl substd. nucleoside derivs. for treatment of hepatitis virus infections
08/13/2003CN1436081A Starter kit for low dose oral contraceptives
08/13/2003CN1436080A Use of cyclic-GMP-specific phosphodiesterase inhibitor for treating parkinson's disease
08/13/2003CN1436079A Imidazopyridine and imidazopyrimidine antiviral agent
08/13/2003CN1436078A Use of (+)-alpha-(2,3-dimethoxyphenyl)1-ÒÇö2-(4-fluorophenyl) ethylÒÇò-4-piperidinemethanol or its prodrug in treatment of symptoms of dementia and dopamine induced psychosis
08/13/2003CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers
1 ... 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 ... 7860